Publication

Article

Pharmaceutical Technology

Pharmaceutical Technology-01-02-2002
Volume26
Issue 1

Investigation of Out-of-Specification Results

Author(s):

James V. McArdle, PhD,Richard J. Davis

The authors summarize the results of the September 2000 PhRMA workshop discussions about conducting out-of-specification investigations.

External Link - article-6989.pdf

Articles in this issue
What Does Pharmacy Automation Mean for Packaging?
Novel Acrylate Adhesives for Transdermal Drug Delivery
Optimal Tablet Press Operation: Machine versus Granulation
Manufacturers Face Shifting Priorities in the New Year
Investigation of Out-of-Specification Results
Reaping the Benefits of E-Procurement

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Subscribe Now!
Related Videos
PharmTech Weekly News Roundup
Related Content
Silver Spring, MD, USA - June 25, 2022: Closeup of the FDA sign seen at its headquarters campus in Silver Spring, Maryland. FDA is a federal agency of the Department of Health and Human Services | Image Credit: © Tada Images - stock.adobe.com.
September 3rd 2025

Pharma Implications of Paul Offit’s Removal from Vaccine Advisory Committee

Christopher Cole
Drug Solutions Podcast: Sustainable Solutions for Biopharma
September 3rd 2025

Drug Solutions Podcast: Sustainable Solutions for Biopharma

Patrick Lavery
Chemistry professor wearing a lab coat and gloves, demonstrating a vibrant chemical solution in a beaker to engaged students during an interactive experiment in a university laboratory | Image Credit: ©DusanJelicic - stock.adobe.com
September 3rd 2025

Focusing on the Fundamentals of Formulation

Evonne Brennan
Drug Solutions Podcast: Novel Drug Delivery Approaches: Refining AAV Vector Deliveries
September 3rd 2025

Drug Solutions Podcast: Novel Drug Delivery Approaches: Refining AAV Vector Deliveries

Patrick Lavery
David Cali is senior director of Security & DEA Compliance at Reworld.
September 3rd 2025

Manufacturer Guidelines for the Secure Destruction of Controlled Substance Pharmaceuticals

David Cali
South San Francisco, CA, USA - Mar 1, 2020: American clinical-stage biopharmaceutical company Cytokinetics, Inc.'s Headquarters in South San Francisco, California. | Image Credit: © Tada Images - stock.adobe.com
September 3rd 2025

Aficamten Bests Metoprolol in Cytokinetics' Trial for Obstructive Hypertrophic Cardiomyopathy

Patrick Lavery
© 2025 MJH Life Sciences

All rights reserved.